Indraprastha Medical Corporation Ltd

Indraprastha Medical Corporation Ltd

₹ 368 -2.85%
15 May - close price
About

Incorporated in 1988 as a JV between Apollo Hospitals Enterprise Ltd. (AHEL) and the Delhi Government, Indraprastha Medical Corporation Ltd. is a super speciality tertiary care hospital in New Delhi. The Co. currently has 52 speciality departments. [1]

Key Points

JV of Apollo
IMCL is a JV between Apollo Hospital (22%) and the State Government of Delhi (26%), and has presence in the NCR with two facilities, a 718-bedded facility in Sarita Vihar (operational since 1996) and a 46-bedded facility in Noida (since 2006). [1]

  • Market Cap 3,371 Cr.
  • Current Price 368
  • High / Low 641 / 342
  • Stock P/E 18.4
  • Book Value 80.8
  • Dividend Yield 1.22 %
  • ROCE 35.8 %
  • ROE 27.5 %
  • Face Value 10.0

Pros

  • Company is almost debt free.
  • Company has delivered good profit growth of 132% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 28.8%
  • Company has been maintaining a healthy dividend payout of 26.3%

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
274 307 317 306 315 348 350 325 334 365 381 372 365
241 259 267 259 266 281 286 273 272 292 310 310 304
Operating Profit 33 47 50 47 48 67 64 52 61 73 71 62 61
OPM % 12% 15% 16% 15% 15% 19% 18% 16% 18% 20% 19% 17% 17%
5 4 4 4 5 5 6 5 6 7 7 7 7
Interest 1 1 1 1 2 2 2 2 1 2 2 1 1
Depreciation 10 10 10 10 10 11 11 11 11 10 11 11 11
Profit before tax 27 40 44 41 42 60 57 45 55 68 66 56 55
Tax % 27% 24% 25% 28% 25% 25% 26% 26% 26% 25% 25% 27% 24%
20 30 33 29 31 45 42 33 41 51 49 41 42
EPS in Rs 2.16 3.33 3.58 3.21 3.40 4.88 4.63 3.58 4.47 5.61 5.40 4.47 4.55
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
714 755 766 753 788 831 613 888 1,099 1,245 1,356 1,483
630 675 686 678 706 743 572 768 947 1,050 1,112 1,216
Operating Profit 85 80 79 74 82 87 41 120 152 195 245 267
OPM % 12% 11% 10% 10% 10% 11% 7% 14% 14% 16% 18% 18%
1 1 -0 -1 -1 -0 -0 -3 9 16 22 29
Interest 8 7 8 9 7 6 3 3 4 4 6 6
Depreciation 28 35 31 31 30 33 33 35 39 40 44 44
Profit before tax 50 39 41 34 45 48 4 79 117 166 216 246
Tax % 34% 37% 36% 38% 36% 9% 46% 26% 26% 25% 26% 25%
32 24 26 21 28 44 2 59 86 124 161 184
EPS in Rs 3.54 2.66 2.86 2.30 3.10 4.76 0.25 6.39 9.40 13.52 17.56 20.03
Dividend Payout % 51% 68% 63% 65% 52% 0% 0% 39% 32% 33% 26% 20%
Compounded Sales Growth
10 Years: 7%
5 Years: 19%
3 Years: 11%
TTM: 9%
Compounded Profit Growth
10 Years: 22%
5 Years: 132%
3 Years: 28%
TTM: 14%
Stock Price CAGR
10 Years: 21%
5 Years: 37%
3 Years: 64%
1 Year: -16%
Return on Equity
10 Years: 21%
5 Years: 27%
3 Years: 29%
Last Year: 27%

Balance Sheet

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 92 92 92 92 92 92 92 92 92 92 92 92
Reserves 103 132 139 141 152 176 181 234 288 386 505 649
50 52 67 66 21 4 3 5 2 34 33 37
196 185 160 134 157 177 157 131 173 212 222 214
Total Liabilities 442 460 458 432 422 449 432 462 555 723 852 991
286 301 296 294 280 303 283 277 275 347 328 365
CWIP 3 3 0 0 1 0 3 0 3 0 33 3
Investments 0 0 0 0 0 0 0 0 0 0 0 0
153 157 163 138 141 146 145 185 278 376 491 624
Total Assets 442 460 458 432 422 449 432 462 555 723 852 991

Cash Flows

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
64 62 28 48 75 86 27 94 144 200 157 167
-29 -33 -22 -30 -17 -40 -19 -74 -108 -158 -111 -178
-35 -30 -5 -17 -44 -43 -3 -3 -26 -32 -46 -46
Net Cash Flow -0 -0 -0 1 14 4 5 17 11 9 -0 -57
Free Cash Flow 35 29 5 17 58 46 6 65 100 131 120 108
CFO/OP 98% 104% 57% 82% 110% 113% 88% 95% 102% 127% 89% 88%

Ratios

Figures in Rs. Crores

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 40 41 47 41 35 35 40 18 23 17 20 28
Inventory Days 11
Days Payable 182
Cash Conversion Cycle 40 41 47 41 35 35 40 18 23 17 20 -144
Working Capital Days -35 -22 -17 -7 -5 -10 -1 -2 -12 -24 -19 -4
ROCE % 23% 18% 17% 15% 19% 21% 3% 29% 34% 38% 39% 36%

Insights

In beta
Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Average Revenue Per Occupied Bed (ARPOB)
INR

Log in to view insights

Please log in to see hidden values.

Login
In-patient Discharges
Number
Out-patient Volumes
Number
Average Length of Stay (ALOS)
Days
Average Bed Occupancy
Percentage
Operational Bed Capacity
Number

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
51.00% 51.00% 51.00% 51.00% 51.00% 51.00% 51.00% 51.00% 51.00% 51.00% 51.00% 51.00%
0.37% 0.81% 0.95% 1.08% 1.70% 2.64% 2.88% 2.94% 2.73% 2.41% 2.72% 2.43%
0.00% 6.71% 6.36% 4.91% 3.14% 3.19% 3.18% 3.56% 3.56% 3.51% 0.82% 0.87%
48.62% 41.49% 41.69% 43.01% 44.14% 43.16% 42.91% 42.50% 42.74% 43.08% 45.43% 45.69%
No. of Shareholders 48,63047,86551,44854,15855,10364,67169,69770,49170,21170,91471,22572,980

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents